tiprankstipranks
Advertisement

SCDV - ETF AI Analysis

Compare

Top Page

SCDV

Bahl & Gaynor Small Cap Dividend ETF (SCDV)

Rating:73Outperform
Price Target:
SCDV, the Bahl & Gaynor Small Cap Dividend ETF, has a solid overall rating driven mainly by strong, profitable companies like The Ensign Group and Victory Capital, which show robust financial performance, smart acquisitions, and supportive dividend policies. Other sizable positions such as Federal Signal, Littelfuse, and BWX Technologies also add strength through growth and healthy cash flow, though several holdings face valuation concerns and occasional weak technical momentum. The main risk factor is that many top holdings appear potentially overvalued or show bearish/neutral trading signals at times, which could increase volatility even though the underlying businesses are generally strong.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains so far this year and in recent months, indicating positive momentum in its strategy.
Strong Top Holdings
Most of the largest positions have delivered positive returns this year, helping support the fund’s overall performance.
Diversified Sector Mix
Holdings are spread across many different sectors, which helps reduce the impact if any one industry runs into trouble.
Negative Factors
High Expense Ratio
The fund’s fee is relatively high for an ETF, which can eat into long-term returns for investors.
Concentration in Industrials and Health Care
A large share of assets is tied up in just two sectors, which could hurt performance if either area weakens.
Limited Geographic Diversification
The ETF is heavily focused on U.S. stocks with only a small allocation to Canada, offering little exposure to other global markets.

SCDV vs. SPDR S&P 500 ETF (SPY)

SCDV Summary

The Bahl & Gaynor Small Cap Dividend ETF (SCDV) focuses on small U.S. and Canadian companies that pay regular dividends, rather than tracking a specific index. It holds a mix of businesses across many sectors, including industrials, health care, and financials. Well-known names in the fund include Gildan Activewear and Tetra Tech. Someone might invest in SCDV to seek a blend of growth potential from smaller companies plus steady income from dividends, while also getting diversification across industries. A key risk is that small-cap stocks can be more volatile, so the ETF’s value can rise and fall sharply with the market.
How much will it cost me?The expense ratio for the Bahl & Gaynor Small Cap Dividend ETF (SCDV) is 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on selecting small-cap stocks with strong dividend-paying capabilities. Active management typically involves higher costs due to the research and analysis required.
What would affect this ETF?The Bahl & Gaynor Small Cap Dividend ETF (SCDV) could benefit from economic growth and increased investor interest in small-cap stocks, particularly in sectors like Industrials and Health Care, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns may negatively impact small-cap companies, as they often face higher borrowing costs and are more sensitive to market volatility. Regulatory changes or sector-specific challenges in industries like Financials or Consumer Cyclical could also affect the ETF's performance.

SCDV Top 10 Holdings

SCDV is leaning heavily into U.S. industrials and health care, and that’s where much of the story sits. Littelfuse and Curtiss-Wright have been doing the heavy lifting, with rising momentum over the past few months, helping offset some recent stumbles. The Ensign Group has also been a steady engine, supporting returns from the health care side. On the flip side, Gildan Activewear and Tetra Tech have been losing steam, acting as mild brakes on performance. Overall, it’s a U.S.-centric, small-cap dividend play with a clear tilt toward industrial strength.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
The Ensign Group8.26%$11.15M$11.65B53.63%
78
Outperform
Curtiss-Wright6.27%$8.46M$23.30B96.01%
74
Outperform
Gildan Activewear5.29%$7.14MC$13.85B19.15%
75
Outperform
Federal Signal4.95%$6.68M$6.38B39.64%
76
Outperform
American Healthcare REIT, Inc.4.69%$6.33M$8.92B52.47%
64
Neutral
Littelfuse4.50%$6.07M$8.04B65.89%
76
Outperform
Victory Capital Holdings4.41%$5.96M$4.16B8.82%
80
Outperform
Enpro4.38%$5.92M$5.11B50.40%
64
Neutral
MSA Safety4.08%$5.51M$6.23B11.47%
75
Outperform
Tetra Tech3.72%$5.02M$7.76B1.93%
73
Outperform

SCDV Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
26.02
Negative
100DMA
25.10
Negative
200DMA
24.66
Positive
Market Momentum
MACD
-0.42
Positive
RSI
42.10
Neutral
STOCH
17.37
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCDV, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 25.31, equal to the 50-day MA of 26.02, and equal to the 200-day MA of 24.66, indicating a neutral trend. The MACD of -0.42 indicates Positive momentum. The RSI at 42.10 is Neutral, neither overbought nor oversold. The STOCH value of 17.37 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SCDV.

SCDV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$133.03M0.70%
73
Outperform
$644.78M0.79%
70
Outperform
$432.16M0.55%
70
Outperform
$164.56M0.36%
65
Neutral
$117.57M0.50%
70
Outperform
$112.39M0.45%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCDV
Bahl & Gaynor Small Cap Dividend ETF
24.88
3.34
15.51%
OSCV
Opus Small Cap Value ETF
SEIS
SEI Select Small Cap ETF
FSCC
Federated Hermes MDT Small Cap Core ETF
SIXS
ETC 6 Meridian Small Cap Equity ETF
FSML
Franklin Small Cap Enhanced ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement